Cargando...
A Novel Approach to Screening for New Neuroprotective Compounds for the Treatment of Stroke
Despite the significant advances that have been made in understanding the pathophysiology of cerebral ischemia on the cellular and molecular level, only one drug, the thrombolytic tissue plasminogen activator (rt-PA), is approved by the FDA for use in patients with acute ischemic stroke. Therefore,...
Gardado en:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2007
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2111291/ https://ncbi.nlm.nih.gov/pubmed/17765210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.brainres.2007.07.061 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|